C07D 239/80
Oxygen atoms
C07D239/80 (Oxygen atoms) appears on 196 US grants and 158 published applications in this corpus.
Search patents in C07D- Granted patents
- 196
- Published applications
- 158
- Assignees
- 114
- Inventors
- 779
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 2 |
| 2002 | 7 | 4 |
| 2003 | 3 | 9 |
| 2004 | 8 | 7 |
| 2005 | 1 | 14 |
| 2006 | 10 | 9 |
| 2007 | 3 | 6 |
| 2008 | 5 | 4 |
| 2009 | 3 | 2 |
| 2010 | 10 | 9 |
| 2011 | 5 | 7 |
| 2012 | 5 | 5 |
| 2013 | 7 | 3 |
| 2014 | 7 | 9 |
| 2015 | 10 | 6 |
| 2016 | 4 | 7 |
| 2017 | 6 | 2 |
| 2018 | 4 | 7 |
| 2019 | 5 | 5 |
| 2020 | 4 | 6 |
| 2021 | 5 | 2 |
| 2022 | 2 | 6 |
| 2023 | 3 | 8 |
| 2024 | 2 | 9 |
| 2025 | 8 | 7 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- 1,4-dihydroquinazolinone compounds and uses thereof30 Dec 2025US 12,509,431 B2Edgewise Therapeutics, Inc.
- 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors23 Dec 2025US 12,503,467 B2Ideaya Biosciences, Inc.
- Substituted quinazolinyl compounds useful as T cell activators9 Dec 2025US 12,492,172 B2Bristol-Myers Squibb Company
- Tetrahydroquinazoline derivatives as selective cytotoxic agents9 Dec 2025US 12,492,183 B2Merck Sharp & Dohme Corp.
- 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors30 Jul 2026US 2026/0217709 A1Ideaya Biosciences, Inc.
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
- Compounds and methods for treating cancer18 Jun 2026US 2026/0166051 A1The Regents of the University of California
- 1,4-dihydroquinazolinone compounds and uses thereof27 Nov 2025US 2025/0361213 A1Edgewise Therapeutics, Inc.
- Kras g12c inhibitors and methods of using the same27 Nov 2025US 2025/0362134 A1Amgen Inc.
Most cited
By later US patents
- Piperidinylalkyl quinazoline compounds, composition and method of use85US 4,335,127 AJanssen Pharmaceutica NV · 1982
- Pyrimidine derivatives79US 7,173,028 B2Boehringer Ingelheim Pharma GMBH & CO.KG · 2007
- Modulation of chemosensory receptors and ligands associated therewith66US 8,633,186 B2Senomyx, Inc. · 2014
- Quinazolinone and benzoxazine derivatives as progesterone receptor modulators64US 6,358,948 B1American Home Products Corporation · 2002
- Bicyclic androgen and progesterone receptor modulator compounds and methods61US 6,566,372 B1Ligand Pharmaceuticals Incorporated · 2003